Health AI’s shift from slideware into salable products shows up plainly in Time’s 2026 Best Inventions list, published this week. More than three dozen medical technologies made the roster, and the composition maps where intelligent tools have reached patients.
Diagnostic software supplies the marquee names. Medical scans and clinical text data are both analyzed by Aidoc’s CARE AI foundation model, which puts urgent cases at the head of the queue. Mayo Clinic’s Radiomics-Based Early Detection Model, or REDMOD, mines a standard CT scan for early pancreatic cancer, catching tumor growth about 16 months sooner than a typical diagnosis would. C the Signs parses patient records and surfaces telltale markers, sometimes years ahead, of tumors in the lung, breast, prostate, colon, pancreas and elsewhere.
Electrical signals drawn from the body are the next front. Oculogica’s SNAP eye test returns a concussion reading in 90 seconds, built for sidelines, emergency departments and clinics. Pathway Labs’ EchoNext reviews routine electrocardiograms for signs of structural heart disease and sends patients on to ultrasound. Less radiation than a CT and no special wiring earned Nanox’s Arc X tomosynthesis scanner its slot, while Medtronic’s Stealth AXiS surgical system and Corsano’s wrist wearable round out the device entries.
Several picks bet on software outliving hardware. Cochlear’s Nucleus Nexa hearing implant takes firmware updates with no follow-up surgery, and Kohler’s Health Dekoda, a clip-on bowl sensor, reads urine for hydration, metabolic markers or blood. Algen Biotechnologies layers CRISPR editing and AI to trace the genetics behind disease, while Amazon’s pharmacy kiosks pair vending with a telehealth line to a pharmacist.
Curated recognition is not clinical proof. For procurement teams, though, the roster signals which categories buyers will ask about, and most are algorithms bolted onto imaging and record systems hospitals already run.
